Skip to content
value.today

Conformal Medical, Inc.

Total raised
$145 M
4 rounds on record
Latest round
$32 M
Jul 2025
First round on record
Nov 2018
Today
Private
No later event on record

Funding rounds

4 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Conformal Medical, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jul 2025$32 MNo. 4$10 to $50 million

Conformal Medical, Inc.: Raise no. 4, Jul 2025

Investors in this round

18 investors had bought by the notice of Aug 13, 2025: 18 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 4 investors are named for Conformal Medical, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$32 M of $33 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Aaron V. Kaplan, MD · Executive Officer, Director
  • James Reinstein · Executive Officer, Director
  • George Fazio · Director
  • Joshua V. Phillips · Director
  • Scott V. Ward · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by James Reinstein, Chief Executive Officer. Source: SEC Form D, newest notice filed Aug 13, 2025. Read the notice at the SEC.

equitySEC
May 2023$35 MNo. 3$10 to $50 million

Conformal Medical, Inc.: Raise no. 3, May 2023

Investors in this round

27 investors had bought by the notice of Jun 8, 2023: 27 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 4 investors are named for Conformal Medical, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$35 M of $35 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Aaron Kaplan · Executive Officer, Director
  • James Reinstein · Executive Officer, Director
  • George Fazio · Director
  • Josh Phillips · Director
  • Scott Ward · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by James Reinstein, Chief Executive Officer. Source: SEC Form D, newest notice filed Jun 8, 2023. Read the notice at the SEC.

equitySEC
Jul 2020$70 MNo. 2$50 to $250 million

Conformal Medical, Inc.: Raise no. 2, Jul 2020

Investors in this round

30 investors had bought by the notice of Aug 10, 2020: 30 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 4 investors are named for Conformal Medical, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$70 M of $85 M offered; $15 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Aaron V. Kaplan · Executive Officer, Director
  • Joshua S. Phillips · Director
  • Scott Ward · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Andy H. Levine, Chief Executive Officer. Source: SEC Form D, newest notice filed Aug 10, 2020. Read the notice at the SEC.

equitySEC
Nov 2018$8 MNo. 1$2 to $10 million

Conformal Medical, Inc.: Raise no. 1, Nov 2018

Investors in this round

24 investors had bought by the notice of Dec 6, 2018: 24 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 4 investors are named for Conformal Medical, Inc. as a whole in other filings: see Investors below.

What the notice says

Amount sold
$8 M of $9 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Aaron V. Kaplan · Executive Officer, Director
  • Andy H. Levine · Executive Officer, Director
  • Joshua S. Phillips · Director
  • Scott S. Ward · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Andy H. Levine, President and Chief Executive Officer. Source: SEC Form D, newest notice filed Dec 6, 2018. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Conformal Medical, Inc. chose not to state its revenue in its newest notice of a funding round (Aug 2025).

    SEC Form D · Aug 2025

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Aug 2025

That is all the official record says: Conformal Medical, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

4 named in official filings. Open an investor to see everything it has backed.

Investors in Conformal Medical, Inc.
InvestorKindAmountRoundRoleSource
Select Medical Technology and Devices PortfolioFund or asset manager$0 Mheldnot statedHolds shares (fund report, May 2026)SEC Form N-PORT
Fidelity Growth Company FundFund or asset manager$0 Mheldnot statedHolds shares (fund report, May 2026)SEC Form N-PORT
Fidelity Growth Company K6 FundFund or asset manager$0 Mheldnot statedHolds shares (fund report, May 2026)SEC Form N-PORT
Fidelity Series Growth Company FundFund or asset manager$0 Mheldnot statedHolds shares (fund report, May 2026)SEC Form N-PORT

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 4 rounds above had up to 30 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Conformal Medical, Inc.
NameRoleNamed in
Aaron V. Kaplan, MDExecutive officerAug 2025
James ReinsteinExecutive officerAug 2025
Aaron KaplanExecutive officerJun 2023
Aaron V. KaplanExecutive officerAug 2020
Andy H. LevineExecutive officerDec 2018
Aaron V. Kaplan, MDDirectorAug 2025
George FazioDirectorAug 2025
James ReinsteinDirectorAug 2025
Joshua V. PhillipsDirectorAug 2025
Scott V. WardDirectorAug 2025
Aaron KaplanDirectorJun 2023
Josh PhillipsDirectorJun 2023
Scott WardDirectorJun 2023
Aaron V. KaplanDirectorAug 2020
Joshua S. PhillipsDirectorAug 2020
Andy H. LevineDirectorDec 2018
Scott S. WardDirectorDec 2018